These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5850641)

  • 1. ["Free" and "bound" plasmatic insulin activity in obese patients treated with phenmetrazine].
    Dascălu R; Gozariu L; Florescu O; Rosan L; Vişinescu I
    Stud Cercet Endocrinol; 1965; 16(3):279-84. PubMed ID: 5850641
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenmetrazine vs. phenmetrazine with amobarbital for weight reduction: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):750-4. PubMed ID: 4984039
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy.
    Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506
    [No Abstract]   [Full Text] [Related]  

  • 4. Obesity: phenmetrazine effect without dietary restriction.
    Huston JR
    Ohio State Med J; 1966 Aug; 62(8):805-7. PubMed ID: 5329662
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
    [No Abstract]   [Full Text] [Related]  

  • 6. Weight reduction with phenmetrazine: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Sep; 9(9):462-7. PubMed ID: 4963979
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight control in obese diabetics. A comparative trial of Filon and phenmetrazine.
    Buckle RM; Silverstone JT
    Br J Clin Pract; 1966 Jul; 20(7):363-5. PubMed ID: 5940969
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in blood lipids in patients treated with reducing diets. Use of delayed-action phenmetrazine].
    Castillo Rosell S; Serrano Maass PA; Bisteni A; Calcáneo F
    Arch Inst Cardiol Mex; 1966; 36(4):454-63. PubMed ID: 5917992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regulation of appetite in obese subjects by means of neutrotropic drugs].
    Gamski M; Komarnicka R
    Pol Tyg Lek; 1968 Oct; 23(44):1688-90. PubMed ID: 5701464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Cafilon in the treatment of obesity (author's transl)].
    Honzák R; Rath R; Vondra K
    Cesk Gastroenterol Vyz; 1976 Apr; 30(3):155-61. PubMed ID: 1277334
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of phenmetrazine on "free" and "bound" plasmatic insulin activity].
    Pora EA; Gozariu L; Madar J; Florescu O; Toma V
    Stud Cercet Endocrinol; 1965; 16(3):253-6. PubMed ID: 5850637
    [No Abstract]   [Full Text] [Related]  

  • 13. The effectiveness of phenmetrazine in obesity.
    Jenner EB
    N Z Med J; 1968 Jan; 67(426):147-9. PubMed ID: 4867885
    [No Abstract]   [Full Text] [Related]  

  • 14. Pondex, a hydantoin derivative, in the management of obesity.
    Krese A; Kiselá J
    Ther Hung; 1968; 16(2):89-90. PubMed ID: 5666420
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucose tolerance and insulinemia in obese patients treated with hydrochlorothiazide].
    Schelling JL; Moody AJ; Felber JP
    Schweiz Med Wochenschr; 1966 Jul; 96(28):909-13. PubMed ID: 5989006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the usefulness of various preparations inhibiting hunger sensation].
    Krotkiewski M; Bielecka J; Ruzyllo E
    Pol Tyg Lek; 1968 Sep; 23(34):1277-80. PubMed ID: 5722527
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change.
    Sletten IW; Sundland D; Pichardo J; Viamontes G
    Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T; Ucar E; Birden F; Yasar O
    Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
    García Pascual IJ; González Ruiz JM
    An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.